Increased cellular responsiveness to insulin-like growth factor-I (IGF-I) has been implicated in several complications associated with diabetes including vascular complications such as atherosclerosis [1–3] and diabetic retinopathy [4–6] as well as other complications such as neuropathy [7–16]. Here, IGF1 is linked to atherosclerosis.